Health
AI-based method used to screen for Alzheimer’s disease drugs – Drug Target Review
Researchers have used artificial intelligence to screen 80 FDA-approved drugs and reveal which could be used as Alzheimer’s treatments.
Posted: 5 March 2021 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have used artificial intelligence to screen 80 FDA-approved drugs and reveal which could be used as Alzheimer’s treatments.
A team at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS), both US, has developed an artificial intelligence (AI)-based method to screen currently available medications as possible treatments for Alzheimer’s disease.
According to the researchers, the method could represent…
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News11 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now